News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,529 Results
Type
Article (44864)
Company Profile (337)
Press Release (698321)
Multimedia
Podcasts (105)
Webinars (19)
Section
Business (212235)
Career Advice (2107)
Deals (36476)
Drug Delivery (110)
Drug Development (82525)
Employer Resources (177)
FDA (16885)
Job Trends (15389)
News (357007)
Policy (33572)
Tag
Academia (2712)
Accelerated approval (15)
Adcomms (24)
Allergies (122)
Alliances (52617)
ALS (137)
Alzheimer's disease (1589)
Antibody-drug conjugate (ADC) (241)
Approvals (16988)
Artificial intelligence (450)
Autoimmune disease (93)
Automation (30)
Bankruptcy (366)
Best Places to Work (11931)
BIOSECURE Act (20)
Biosimilars (154)
Biotechnology (221)
Bladder cancer (135)
Brain cancer (45)
Breast cancer (507)
Cancer (3975)
Cardiovascular disease (326)
Career advice (1779)
Career pathing (34)
CAR-T (242)
CDC (43)
Cell therapy (645)
Cervical cancer (31)
Clinical research (69167)
Collaboration (1397)
Company closure (4)
Compensation (952)
Complete response letters (45)
COVID-19 (2770)
CRISPR (82)
C-suite (601)
Cystic fibrosis (137)
Data (4916)
Decentralized trials (2)
Denatured (42)
Depression (99)
Diabetes (436)
Diagnostics (6825)
Digital health (36)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (204)
Drug pricing (160)
Drug shortages (30)
Duchenne muscular dystrophy (201)
Earnings (90988)
Editorial (48)
Employer branding (22)
Employer resources (156)
Events (120564)
Executive appointments (965)
FDA (19420)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1257)
Gene editing (175)
Generative AI (38)
Gene therapy (518)
GLP-1 (904)
Government (4714)
Grass and pollen (7)
Guidances (372)
Healthcare (19582)
HIV (46)
Huntington's disease (36)
IgA nephropathy (65)
Immunology and inflammation (214)
Immuno-oncology (17)
Indications (60)
Infectious disease (3002)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (97)
Intellectual property (201)
Interviews (327)
IPO (16959)
IRA (49)
Job creations (3828)
Job search strategy (1499)
Kidney cancer (15)
Labor market (75)
Layoffs (549)
Leadership (29)
Legal (8162)
Liver cancer (87)
Longevity (11)
Lung cancer (559)
Lymphoma (282)
Machine learning (32)
Management (63)
Manufacturing (620)
MASH (138)
Medical device (14384)
Medtech (14412)
Mergers & acquisitions (20427)
Metabolic disorders (1079)
Multiple sclerosis (134)
NASH (16)
Neurodegenerative disease (206)
Neuropsychiatric disorders (50)
Neuroscience (2580)
NextGen: Class of 2025 (6850)
Non-profit (4634)
Now hiring (59)
Obesity (503)
Opinion (254)
Ovarian cancer (141)
Pain (156)
Pancreatic cancer (174)
Parkinson's disease (232)
Partnered (29)
Patents (423)
Patient recruitment (336)
Peanut (55)
People (60562)
Pharmaceutical (70)
Pharmacy benefit managers (25)
Phase I (21687)
Phase II (30411)
Phase III (22595)
Pipeline (2969)
Policy (257)
Postmarket research (2583)
Preclinical (9341)
Press Release (71)
Prostate cancer (196)
Psychedelics (42)
Radiopharmaceuticals (276)
Rare diseases (632)
Real estate (6265)
Recruiting (69)
Regulatory (24165)
Reports (51)
Research institute (2497)
Resumes & cover letters (363)
Rett syndrome (17)
RNA editing (14)
RSV (69)
Schizophrenia (129)
Series A (205)
Series B (152)
Service/supplier (15)
Sickle cell disease (78)
Special edition (20)
Spinal muscular atrophy (150)
Sponsored (37)
Startups (3865)
State (2)
Stomach cancer (14)
Supply chain (95)
Tariffs (79)
The Weekly (61)
Vaccines (952)
Venture capital (67)
Weight loss (330)
Women's health (59)
Worklife (17)
Date
Last 7 days (1089)
Last 30 days (3069)
Last 365 days (31131)
2025 (26960)
2024 (36219)
2023 (41136)
2022 (52398)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33540)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (771)
Alabama (75)
Alaska (7)
Arizona (284)
Arkansas (14)
Asia (41431)
Australia (6887)
California (9792)
Canada (2911)
China (901)
Colorado (407)
Connecticut (425)
Delaware (282)
Europe (90970)
Florida (1441)
Georgia (318)
Hawaii (2)
Idaho (63)
Illinois (751)
India (50)
Indiana (471)
Iowa (19)
Japan (333)
Kansas (123)
Kentucky (36)
Louisiana (21)
Maine (69)
Maryland (1265)
Massachusetts (7197)
Michigan (309)
Minnesota (568)
Mississippi (4)
Missouri (120)
Montana (32)
Nebraska (25)
Nevada (107)
New Hampshire (79)
New Jersey (2674)
New Mexico (29)
New York (2616)
North Carolina (1331)
North Dakota (10)
Northern California (4581)
Ohio (296)
Oklahoma (21)
Oregon (40)
Pennsylvania (2028)
Puerto Rico (20)
Rhode Island (44)
South America (1157)
South Carolina (51)
South Dakota (1)
Southern California (3771)
Tennessee (151)
Texas (1501)
United States (35413)
Utah (294)
Virginia (230)
Washington D.C. (78)
Washington State (814)
West Virginia (4)
Wisconsin (90)
Wyoming (2)
743,529 Results for "nanotemper technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α
November 6, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
September 11, 2025
·
4 min read
Press Releases
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
September 11, 2025
·
3 min read
Press Releases
Medical Care Technologies Inc. Unveils Breakthrough AI for Early Melanoma Detection
September 18, 2025
·
1 min read
Press Releases
BioSig Technologies Inc. Announces Proposed Public Offering
August 13, 2025
·
4 min read
Press Releases
Medical Care Technologies Inc. Launches AI Platform for Early Basal Cell Carcinoma Detection
September 22, 2025
·
1 min read
Press Releases
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
October 10, 2025
·
4 min read
Biotech Bay
NanoTemper Technologies Unveils Biotinylated Target Labeling Kit, Empowering Scientists in Pharma Industry to Tackle Challenging Drug Targets
NanoTemper Technologies, creator of biophysical tools for drug discovery, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry.
June 29, 2023
·
2 min read
Press Releases
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
August 13, 2025
·
4 min read
Press Releases
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
August 15, 2025
·
8 min read
1 of 74,353
Next
